spacer
 
|

Click below to register.

Wednesday, October 3rd, 2018
San Francisco, California

Moscone Convention Center
Room: Moscone South 206-208


11:00 AM – 11:30 AM: Registration and Lunch
11:30 AM – 1:00 PM: Interactive CME Activity

ACTIVITY OVERVIEW
The increasing prevalence of infections due to multidrug-resistant (MDR) gram-negative bacteria is associated with increased morbidity and mortality and prolonged hospitalization, which contributes to a significant burden on healthcare systems. In particular, complicated intraabdominal (IAI) and urinary tract infections (UTIs) have emerged as particularly serious concerns. Despite increased understanding of the factors that contribute to the persistence and spread of MDR gram-negative bacteria and global efforts to address these factors, the rising prevalence of infections due to MDR gram-negative bacteria presents a significant challenge in selecting empiric antimicrobial therapy for seriously ill hospitalized patients. This live interactive symposium, presented by 3 international infectious diseases experts, will provide a review of the current epidemiology of complicated IAI, UTI, and MDR gram-negative bacterial infections, discuss specific issues with hospital/intensive-care unit infections, and focus on problem pathogens, infection control, and risk stratification. Faculty will also review the role of novel antibacterial agents with these infections and will also present an interactive case study to showcase how the most up-to-date information can be used to manage complicated gram-negative infections in hospitalized patients.

GOAL
To provide healthcare professionals who treat hospitalized patients with MDR gram-negative bacterial infections with the most up-to-date information on best practices for preventing these infections, treating them effectively and empirically when they do arise, and newer antibacterial agents that are becoming or are available.

TARGET AUDIENCE
This educational activity is designed for infectious disease, critical care, hospital medicine providers, and other healthcare providers responsible for the management of patients with gram-negative infections, who will be in attendance at IDWeek 2018. There are no prerequisites.

PROGRAM OBJECTIVES
At the conclusion of the program, participants will be able to:
  • DESCRIBE the current challenges with the treatment of complicated and multi-drug resistant (MDR) gram-negative intra-abdominal and urinary tract infections.
  • ASSESS appropriate risk stratification strategies to optimize outcomes with MDR gram-negative intra-abdominal and urinary tract infections.
  • EVALUATE emerging antibiotic treatment options for MDR gram-negative intra-abdominal and urinary tract infections.

AGENDA
11:00 AM – 11:30 AM Activity Registration and Lunch
11:30 AM – 11:35 AM Introduction
Andrew Shorr, MD, MPH
11:35 AM – 12:00 PM Setting the Stage - Gram-Negative Resistance in the ICU: Epidemiology, Outcomes, and Strategies
Andrew Shorr, MD, MPH
12:00 PM – 12:25 PM Current Challenges in Complicated Gram-negative Infections
Brad Spellberg, MD
12:25 PM – 12:50 PM Emerging Treatment Options for Multidrug Resistant Gram-Negative Intra-abdominal and Urinary Tract Infections
Keith A. Rodvold, PharmD, FCCP, FIDSA
12:50 PM – 1:00 PM Case Study, Discussion, and Conclusions
Faculty Panel

The agenda is subject to change and was provided by: ASiM CE, LLC; 166 West Main St; Somerville, NJ; 908-253-9001; Fax: 908-253-9002.
Please contact Cathy Zehr directly at 908-253-9001 ext.15 or czehr@asimcme.com for more information.

FACULTY
Andrew Shorr, MD, MPH (Chair)
Director of Pulmonary and Critical Care Medicine
Director, Medical Intensive Care Unit
MedStar Washington Hospital Center
Professor of Medicine
Georgetown University School of Medicine
Washington, DC

Keith A. Rodvold, PharmD, FCCP, FIDSA
Professor of Pharmacy Practice and Medicine
Colleges of Pharmacy and Medicine
University of Illinois at Chicago
Chicago, Illinois

Brad Spellberg, MD
Chief Medical Officer
Los Angeles County, University of Southern California Medical Center
Professor of Clinical Medicine
Associate Dean for Clinical Affairs
Keck School of Medicine
Los Angeles, California

ACCREDITATION STATEMENT
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc, Advancing Knowledge in Healthcare and ASiM CE, LLC. AKH Inc, Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc, Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CRITERIA FOR SUCCESS
Statements of credit will be awarded based on the participant's attendance, participation in the pre/post-test, and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at ADD AKH EVAL LINK HERE . If you have questions about this CME activity, please contact AKH Inc. at tbrignoni@akhcme.com.

AMERICANS WITH DISABILITIES ACT (ADA)
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Cathy Zehr prior to the live event at 908-253-9001 ext. 15 or czehr@asimcme.com for more information.

FEE INFORMATION
There is no fee for this educational activity.

Submit a case to review at meeting:


<img src="http://www.jhasio1.com/asim/pictures/proceed_pretestASIM.png" alt="procced to pretest" border="0" />


spacer  
  spacer
MyCMESite is published by ASiM CE, LLC, d/b/a ASiM 166 W. Main Street, Somerville, NJ 08876. (908) 253-9001. Copyright ©2017 by ASiM CE, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of ASiM CE LLC. Contact Us
spacer  
spacer